Neose Technologies Earnings Conference Call (Q1 2008)  Today's Calls

Visit the TF Network Sites· Corporate IR Center · Institutional Investor Center · Individual Investor Center Download Plug-In Real Player 8 Basic Windows Media Player Other Conference Calls Other May 8 Calls Today's Calls

Call Details Neose Technologies Earnings Conference Call (Q1 2008) Thu, May 8, 2008, 5:00 pm Eastern Listen to the archived event audio About Neose Technologies (NasdaqGM:NTEC) Neose Technologies, Inc., a clinical-stage biopharmaceutical company, focuses on the development of next-generation therapeutic proteins. The company offers products based on the GlycoPEGylation technology that involves the use of enzymes to attach PEG to carbohydrate structures on proteins. Its therapeutic protein candidates in development stage include GlycoPEG-GCSF, a phase-I completed product, for the treatment of neutropenia associated with myelosuppressive chemotherapy; and GlycoPEG-FVIIa for the treatment of bleeding episodes and for the prevention of bleeding during surgery or invasive procedures in patients with congenital hemophilia with inhibitors to coagulation factors VIII or IX. The company’s research stage products include GlycoPEG-FVIII for the treatment of Hemophilia A; and GlycoPEG-FIX for the treatment of Hemophilia B. It has collaborations with BioGeneriX AG; and Novo Nordisk A/S. Neose Technologies, Inc. was founded in 1989 and is headquartered in Horsham, Pennsylvania. More Info: Quote | Chart | News | Profile | Reports | Research | SEC | Msgs | Insider | Financials | Analyst Ratings